NO884565D0 - Preparat for kontrastdannelse ved diagnose av ondartet neoplasma. - Google Patents

Preparat for kontrastdannelse ved diagnose av ondartet neoplasma.

Info

Publication number
NO884565D0
NO884565D0 NO884565A NO884565A NO884565D0 NO 884565 D0 NO884565 D0 NO 884565D0 NO 884565 A NO884565 A NO 884565A NO 884565 A NO884565 A NO 884565A NO 884565 D0 NO884565 D0 NO 884565D0
Authority
NO
Norway
Prior art keywords
departured
neoplasma
disposition
diagnosis
preparation
Prior art date
Application number
NO884565A
Other languages
English (en)
Other versions
NO884565L (no
Inventor
Nikolai Nikolaevich Dzbanovsky
Viktor Iosifovich Polsachev
Elena Vasilievna Potemkina
Alexandr Tursunovich Rakhimov
Leonid Borisovich Rubin
Alexandr Sergeevich Osipov
Original Assignee
Univ Moskovsk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Moskovsk filed Critical Univ Moskovsk
Publication of NO884565D0 publication Critical patent/NO884565D0/no
Publication of NO884565L publication Critical patent/NO884565L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pyrane Compounds (AREA)
NO88884565A 1987-10-15 1988-10-13 Preparat for kontrastdannelse ved diagnose av ondartet neoplasma. NO884565L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU4313068 1987-10-15

Publications (2)

Publication Number Publication Date
NO884565D0 true NO884565D0 (no) 1988-10-13
NO884565L NO884565L (no) 1989-04-17

Family

ID=21330433

Family Applications (2)

Application Number Title Priority Date Filing Date
NO88884565A NO884565L (no) 1987-10-15 1988-10-13 Preparat for kontrastdannelse ved diagnose av ondartet neoplasma.
NO88884566A NO884566L (no) 1987-10-15 1988-10-13 Anvendelse av fluorderivater og kontrastpreparat for diagnostisering av ondartede neoplasmer.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO88884566A NO884566L (no) 1987-10-15 1988-10-13 Anvendelse av fluorderivater og kontrastpreparat for diagnostisering av ondartede neoplasmer.

Country Status (7)

Country Link
US (1) US5093106A (no)
EP (3) EP0312108B1 (no)
JP (2) JPH01211531A (no)
BR (2) BR8805356A (no)
DE (1) DE3872481D1 (no)
FI (2) FI884721A (no)
NO (2) NO884565L (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3038339B2 (ja) * 1988-05-02 2000-05-08 ザイナクシス・テクノロジーズ・インコーポレーテッド バイオ粒子の表面膜に対してバイオアフェクティング物質を結合する化合物
EP0539432B1 (en) * 1990-07-19 1998-11-25 Unicliffe Limited Diagnostic compositions for assessment of pancreatic insufficiency
EP0521568B1 (en) * 1991-07-05 1996-09-18 Tokyo Gas Co., Ltd. A low-nox gas burner
US5995645A (en) * 1993-08-18 1999-11-30 Applied Spectral Imaging Ltd. Method of cancer cell detection
US6159445A (en) * 1994-07-20 2000-12-12 Nycomed Imaging As Light imaging contrast agents
GB9502065D0 (en) * 1995-02-02 1995-03-22 Nycomed Imaging As Contrast media
US6540981B2 (en) 1997-12-04 2003-04-01 Amersham Health As Light imaging contrast agents
US5840713A (en) * 1995-04-03 1998-11-24 Weisz; Paul B. Therapy for tissue membrane insufficiency
GB9607503D0 (en) * 1996-04-11 1996-06-12 Merck Frosst Canada Inc Bisaryl cyclobutenes derivatives as cyclooxygenase inhibitors
US20040082863A1 (en) * 2002-03-15 2004-04-29 Mcgreevy James Device and method for the photodynamic diagnosis of tumor tissue
RU2235323C2 (ru) * 2002-05-14 2004-08-27 Российский НИИ геронтологии Способ диагностики злокачественных новообразований
US7854705B2 (en) * 2004-12-16 2010-12-21 Olga Pawluczyk Ex vivo verification of biopsy tissue samples
WO2007025238A2 (en) * 2005-08-24 2007-03-01 Cedars-Sinai Medical Center Use of fructose-based therapies for the treatment of cancer
CA2948306A1 (en) * 2014-05-14 2015-11-19 The University Of Tokyo Enzyme-specific fluorescent compound capable of being retained in cells
CN104844674B (zh) * 2015-04-30 2019-11-12 赛纳生物科技(北京)有限公司 新型聚合酶底物：荧光可产生多聚磷酸末端标记核苷酸及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2704270A (en) * 1951-04-16 1955-03-15 Leo Ab Antihistaminic injectable X-ray contrast media
FR255F (no) * 1967-02-17
BE724644A (no) * 1967-12-07 1969-05-02
SU792878A1 (ru) * 1978-08-29 1982-02-07 Ленинградский институт ядерной физики им. Б.П.Константинова Способ получени галогенированных производных флуоресцеина,меченных радиоизотопом йода
US4256727A (en) * 1978-09-18 1981-03-17 The University Of Kentucky Research Foundation Synthesis and use of diagnostic radio-pharmaceuticals comprising radioactive isotopes of bromine with dyes
US4401755A (en) * 1981-01-29 1983-08-30 Massachusetts Institute Of Technology Process for measuring microbiologically active material
FR2504408B1 (fr) * 1981-04-24 1986-02-14 Couvreur Patrick Procede de preparation de particules submicroscopiques, particules ainsi obtenues et compositions pharmaceutiques les contenant
US4350676A (en) * 1981-05-21 1982-09-21 Laties Alan M Ophthalmic use of carboxyfluorescein
US4820505A (en) * 1985-04-04 1989-04-11 Scripps Clinic And Research Foundation Detection of activated platelets with antibodies to thrombospondin
US4695654A (en) * 1985-08-21 1987-09-22 Merrell Dow Pharmaceuticals Inc. Gem-dihalo-1,8-diamino-4-aza-octanes
JPS6277336A (ja) * 1985-10-01 1987-04-09 Nippon Sekigaisen Kogyo Kk ガン診断用試薬
US4912208A (en) * 1987-06-29 1990-03-27 Abbott Laboratories Fluorophores for encapsulation into liposomes

Also Published As

Publication number Publication date
NO884566D0 (no) 1988-10-13
FI884721A (fi) 1989-04-16
FI884720A (fi) 1989-04-16
EP0454185A2 (de) 1991-10-30
EP0313942A1 (de) 1989-05-03
FI884720A0 (fi) 1988-10-13
FI884721A0 (fi) 1988-10-13
JPH01211531A (ja) 1989-08-24
US5093106A (en) 1992-03-03
BR8805356A (pt) 1989-06-13
EP0454185A3 (en) 1992-01-08
EP0312108B1 (de) 1992-07-01
EP0312108A1 (de) 1989-04-19
JPH01221329A (ja) 1989-09-04
NO884566L (no) 1989-04-17
BR8805359A (pt) 1989-06-13
NO884565L (no) 1989-04-17
DE3872481D1 (de) 1992-08-06

Similar Documents

Publication Publication Date Title
NO882169L (no) Fremgangsmaate ved oksydering av hydrokarboner.
NO885106D0 (no) FremgangsmŸte ved fremstilling av cytidin-derivater.
NO881881D0 (no) Fremgangsmaate ved fremstilling av detergentblanding.
NO882778D0 (no) Fremgangsmaate ved oksydering av alkaner.
NO884565D0 (no) Preparat for kontrastdannelse ved diagnose av ondartet neoplasma.
NO875134D0 (no) Fremgangsmaate ved fremstilling av smoereolje.
NO880068D0 (no) Fremgangsmaate ved fremstilling av heteroaryl-3-okso-propannitrilderivater.
NO894011D0 (no) Fremgangsmaate ved oksydering av alkaner.
NO884665D0 (no) Fremgangsmaate ved fremstilling av 9-oh-alkoksyguanin.
NO875496D0 (no) Fremgangsmaate ved oksydering av hydrokarboner.
NO872809L (no) FremgangsmŸte ved fremstilling av 5-amino-alicylsyre.
NO170022C (no) Fremgangsmaate for fremstilling av sialocylglycerolipider.
NO882730D0 (no) Fremgangsmaate for fremstilling av aminocyklopentyletere.
NO905364L (no) Fremgangsmaate ved fremstilling av alkansyrederivater.
NO885591D0 (no) Fremgangsmaate for fremstilling av substituerte aromatiske forbindelser.
NO881388D0 (no) Fremgangsmaate for fremstilling av 4-fenylpiperidin-forbindelser.
NO169338C (no) Fremgangsmaate for fremstilling av 5h-dibenz(b,f)azepin-5-karboksamid(karbamazepin)
NO881055L (no) Fremgangsmaate ved fremstilling av okso-isoindolinyl-derivater.
NO880409D0 (no) Fremgangsmaate for fremstilling av 14,15-substituerte lanosteroler.
NO870543L (no) Fremgangsmaate ved fremstilling av 4-acetylisokinolinonforbindelser.
NO880834D0 (no) Fremgangsmaate for fremstilling av heterocyclyl-2-propyn-1-aminer.
NO880127D0 (no) Fremgangsmaate for fremstilling av (+-)-1,2-dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1,7-dicarboxylater.
NO873813L (no) Fremgangsmaate for fremstilling av et (metylsubstituert) difenylmetan.
NO913089D0 (no) Fremgangsmaate for fremstilling av tetrazolforbindelser.
NO880878D0 (no) Fremgangsmaate for fremstilling av aldehyder ved hydroformylering.